These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
289 related items for PubMed ID: 10786685
1. E-7869 (R-flurbiprofen) inhibits progression of prostate cancer in the TRAMP mouse. Wechter WJ, Leipold DD, Murray ED, Quiggle D, McCracken JD, Barrios RS, Greenberg NM. Cancer Res; 2000 Apr 15; 60(8):2203-8. PubMed ID: 10786685 [Abstract] [Full Text] [Related]
2. Genistein in the diet reduces the incidence of poorly differentiated prostatic adenocarcinoma in transgenic mice (TRAMP). Mentor-Marcel R, Lamartiniere CA, Eltoum IE, Greenberg NM, Elgavish A. Cancer Res; 2001 Sep 15; 61(18):6777-82. PubMed ID: 11559550 [Abstract] [Full Text] [Related]
3. Chemoprevention of prostate carcinogenesis by alpha-difluoromethylornithine in TRAMP mice. Gupta S, Ahmad N, Marengo SR, MacLennan GT, Greenberg NM, Mukhtar H. Cancer Res; 2000 Sep 15; 60(18):5125-33. PubMed ID: 11016639 [Abstract] [Full Text] [Related]
4. R-flurbiprofen chemoprevention and treatment of intestinal adenomas in the APC(Min)/+ mouse model: implications for prophylaxis and treatment of colon cancer. Wechter WJ, Kantoci D, Murray ED, Quiggle DD, Leipold DD, Gibson KM, McCracken JD. Cancer Res; 1997 Oct 01; 57(19):4316-24. PubMed ID: 9331093 [Abstract] [Full Text] [Related]
5. Androgen-independent prostate cancer progression in the TRAMP model. Gingrich JR, Barrios RJ, Kattan MW, Nahm HS, Finegold MJ, Greenberg NM. Cancer Res; 1997 Nov 01; 57(21):4687-91. PubMed ID: 9354422 [Abstract] [Full Text] [Related]
6. OSU-HDAC42, a histone deacetylase inhibitor, blocks prostate tumor progression in the transgenic adenocarcinoma of the mouse prostate model. Sargeant AM, Rengel RC, Kulp SK, Klein RD, Clinton SK, Wang YC, Chen CS. Cancer Res; 2008 May 15; 68(10):3999-4009. PubMed ID: 18483287 [Abstract] [Full Text] [Related]
7. Dietary feeding of silibinin inhibits prostate tumor growth and progression in transgenic adenocarcinoma of the mouse prostate model. Raina K, Blouin MJ, Singh RP, Majeed N, Deep G, Varghese L, Glodé LM, Greenberg NM, Hwang D, Cohen P, Pollak MN, Agarwal R. Cancer Res; 2007 Nov 15; 67(22):11083-91. PubMed ID: 18006855 [Abstract] [Full Text] [Related]
8. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies). National Toxicology Program . Natl Toxicol Program Tech Rep Ser; 1993 Sep 15; 422():1-340. PubMed ID: 12616289 [Abstract] [Full Text] [Related]
9. Efficacious chemoprevention of primary prostate cancer by flutamide in an autochthonous transgenic model. Raghow S, Kuliyev E, Steakley M, Greenberg N, Steiner MS. Cancer Res; 2000 Aug 01; 60(15):4093-7. PubMed ID: 10945615 [Abstract] [Full Text] [Related]
10. Regression of mouse prostatic intraepithelial neoplasia by nonsteroidal anti-inflammatory drugs in the transgenic adenocarcinoma mouse prostate model. Narayanan BA, Narayanan NK, Pittman B, Reddy BS. Clin Cancer Res; 2004 Nov 15; 10(22):7727-37. PubMed ID: 15570007 [Abstract] [Full Text] [Related]
11. Expression pattern of mouse homolog of prostate-specific membrane antigen (FOLH1) in the transgenic adenocarcinoma of the mouse prostate model. Schmittgen TD, Zakrajsek BA, Hill RE, Liu Q, Reeves JJ, Axford PD, Singer MJ, Reed MW. Prostate; 2003 Jun 01; 55(4):308-16. PubMed ID: 12712410 [Abstract] [Full Text] [Related]